ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer

[1]  Pavel Sumazin,et al.  Restoration of the molecular clock is tumor suppressive in neuroblastoma , 2021, Nature Communications.

[2]  Shannon M. Mumenthaler,et al.  Clocking cancer: the circadian clock as a target in cancer therapy , 2021, Oncogene.

[3]  W. Dowhan,et al.  Nobiletin: Targeting the Circadian Network to Promote Bioenergetics and Healthy Aging , 2020, Biochemistry (Moscow).

[4]  Shihoko Kojima,et al.  Genome-wide correlation analysis to identify amplitude regulators of circadian transcriptome output , 2020, Scientific Reports.

[5]  J. Hogenesch,et al.  NF-κB modifies the mammalian circadian clock through interaction with the core clock protein BMAL1 , 2020, bioRxiv.

[6]  K. Yagita,et al.  Circadian regulation of chemotherapy-induced peripheral neuropathic pain and the underlying transcriptomic landscape , 2020, Scientific Reports.

[7]  W. Dowhan,et al.  Cardiolipin Synthesis in Skeletal Muscle Is Rhythmic and Modifiable by Age and Diet , 2020, Oxidative medicine and cellular longevity.

[8]  R. Mohammadinejad,et al.  Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways , 2020, Biomedicines.

[9]  Xi Zheng,et al.  Nobiletin, a citrus polymethoxyflavone, enhances the effects of bicalutamide on prostate cancer cells via down regulation of NF-κB, STAT3, and ERK activation , 2020, RSC advances.

[10]  Yang Jiang,et al.  MiR-18a-downregulated RORA inhibits the proliferation and tumorigenesis of glioma using the TNF-α-mediated NF-κB signaling pathway , 2020, EBioMedicine.

[11]  D. Sage,et al.  In pancreatic islets from type 2 diabetes patients, the dampened circadian oscillators lead to reduced insulin and glucagon exocytosis , 2020, Proceedings of the National Academy of Sciences.

[12]  Stephanie R. Taylor,et al.  Nobiletin affects circadian rhythms and oncogenic characteristics in a cell-dependent manner , 2020, bioRxiv.

[13]  K. Lam,et al.  RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype , 2019, Nature Communications.

[14]  A. D’Alessandro,et al.  Coordinate Regulation of Cholesterol and Bile Acid Metabolism by the Clock Modifier Nobiletin in Metabolically Challenged Old Mice , 2019, International Journal of Molecular Sciences.

[15]  J. Takahashi,et al.  Nobiletin fortifies mitochondrial respiration in skeletal muscle to promote healthy aging against metabolic challenge , 2019, Nature Communications.

[16]  Satchidananda Panda,et al.  Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment. , 2019, Trends in cancer.

[17]  Yu Zheng,et al.  Nobiletin Inhibits Cell Viability via the SRC/AKT/STAT3/YY1AP1 Pathway in Human Renal Carcinoma Cells , 2019, Front. Pharmacol..

[18]  Kok-Gan Chan,et al.  Nobiletin and Derivatives: Functional Compounds from Citrus Fruit Peel for Colon Cancer Chemoprevention , 2019, Cancers.

[19]  S. Wiemann,et al.  Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer , 2019, Front. Immunol..

[20]  Yan Feng,et al.  Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity. , 2018, Cell reports.

[21]  G. Barish,et al.  Requirement for NF-κB in maintenance of molecular and behavioral circadian rhythms in mice , 2018, Genes & development.

[22]  F. Sladek,et al.  Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma , 2018, Nature Communications.

[23]  G. Mills,et al.  The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy. , 2018, Cell systems.

[24]  S. Mocellin,et al.  Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies , 2018, BMC Medicine.

[25]  Dennis L. Buckley,et al.  Acute Pharmacologic Degradation of a Stable Antigen Enhances Its Direct Presentation on MHC Class I Molecules , 2018, Front. Immunol..

[26]  Albertha J. M. Walhout,et al.  Gateway Recombinational Cloning. , 2018, Cold Spring Harbor protocols.

[27]  Junhyong Kim,et al.  CYCLOPS reveals human transcriptional rhythms in health and disease , 2017, Proceedings of the National Academy of Sciences.

[28]  S. Shibata,et al.  Potent Effects of Flavonoid Nobiletin on Amplitude, Period, and Phase of the Circadian Clock Rhythm in PER2::LUCIFERASE Mouse Embryonic Fibroblasts , 2017, PloS one.

[29]  Joseph S. Takahashi,et al.  Transcriptional architecture of the mammalian circadian clock , 2016, Nature Reviews Genetics.

[30]  A. Sayad,et al.  Retinoic acid-related orphan receptor alpha (RORA) variants and risk of breast cancer. , 2017, Breast disease.

[31]  M. Karin,et al.  Targeting Inflammation in Cancer Prevention and Therapy , 2016, Cancer Prevention Research.

[32]  J. Balko,et al.  Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease , 2016, Nature Reviews Clinical Oncology.

[33]  Brett Fleisher,et al.  Breast Cancer -targets and Therapy Dovepress Current Advances in Biomarkers for Targeted Therapy in Triple-negative Breast Cancer , 2022 .

[34]  Hao Huang,et al.  The Multifunctional Effects of Nobiletin and Its Metabolites In Vivo and In Vitro , 2016, Evidence-based complementary and alternative medicine : eCAM.

[35]  T. Jacks,et al.  Circadian Rhythm Disruption Promotes Lung Tumorigenesis. , 2016, Cell metabolism.

[36]  M. Huff,et al.  Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis. , 2016, Annual review of nutrition.

[37]  J. Takahashi,et al.  The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic Syndrome. , 2016, Cell metabolism.

[38]  Michelle C. Chen,et al.  Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML , 2016, Cell.

[39]  Bipul R. Acharya,et al.  The Nuclear Receptor, RORγ, Regulates Pathways Necessary for Breast Cancer Metastasis , 2016, EBioMedicine.

[40]  K. Gogineni,et al.  A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer , 2016, Breast cancer : basic and clinical research.

[41]  Wenzhe Ma,et al.  Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells , 2015, Scientific Reports.

[42]  C. Dang,et al.  MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells. , 2015, Cell Metabolism.

[43]  Noheon Park,et al.  Ammonia-lowering activities and carbamoyl phosphate synthetase 1 (Cps1) induction mechanism of a natural flavonoid , 2015, Nutrition & Metabolism.

[44]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[45]  S. Grimmond,et al.  PRMT2 and RORγ expression are associated with breast cancer survival outcomes. , 2014, Molecular endocrinology.

[46]  C. Chen,et al.  Antiproliferative and apoptosis-inducing activity of nobiletin against three subtypes of human breast cancer cell lines. , 2014, Anticancer research.

[47]  Douglas J. Kojetin,et al.  REV-ERB and ROR nuclear receptors as drug targets , 2014, Nature Reviews Drug Discovery.

[48]  S. Aparicio,et al.  The omics of triple-negative breast cancers. , 2014, Clinical chemistry.

[49]  A. Børresen-Dale,et al.  Triple-negative breast cancer and the need for new therapeutic targets. , 2013, The American journal of pathology.

[50]  A. Schally,et al.  Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers. , 2013, Oncology reports.

[51]  Melissa J. Davis,et al.  Research resource: nuclear receptors as transcriptome: discriminant and prognostic value in breast cancer. , 2013, Molecular endocrinology.

[52]  J. Li,et al.  Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line , 2013, Cancer Cell International.

[53]  Jun Du,et al.  RORα, a Potential Tumor Suppressor and Therapeutic Target of Breast Cancer , 2012, International journal of molecular sciences.

[54]  K. Ahn,et al.  Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9 , 2012, Pharmaceutical biology.

[55]  M. Antoch,et al.  Core circadian protein CLOCK is a positive regulator of NF-κB–mediated transcription , 2012, Proceedings of the National Academy of Sciences.

[56]  S. Panda,et al.  Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines , 2012, Proceedings of the National Academy of Sciences.

[57]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[58]  Brad T. Sherman,et al.  DAVID-WS: a stateful web service to facilitate gene/protein list analysis , 2012, Bioinform..

[59]  Prachi Sharma,et al.  Bioavailability of Citrus Polymethoxylated Flavones and Their Biological Role in Metabolic Syndrome and Hyperlipidemia , 2012 .

[60]  G. Xiong,et al.  RORα suppresses breast tumor invasion by inducing SEMA3F expression. , 2012, Cancer research.

[61]  D. Hwang,et al.  DNA damage-induced RORα is crucial for p53 stabilization and increased apoptosis. , 2011, Molecular cell.

[62]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[63]  N. Perkins,et al.  Regulation of the RelA (p65) transactivation domain. , 2008, Biochemical Society transactions.

[64]  G. Muscat,et al.  The orphan nuclear receptor, RORalpha, regulates gene expression that controls lipid metabolism: staggerer (SG/SG) mice are resistant to diet-induced obesity. , 2008, The Journal of biological chemistry.

[65]  Steve A. Kay,et al.  Redundant Function of REV-ERBα and β and Non-Essential Role for Bmal1 Cycling in Transcriptional Regulation of Intracellular Circadian Rhythms , 2008, PLoS genetics.

[66]  N. Perkins,et al.  Regulation of the RelA ( p 65 ) transactivation domain , 2008 .

[67]  T. Walle.  Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? , 2007, Seminars in cancer biology.

[68]  Francis J. Doyle,et al.  Intercellular Coupling Confers Robustness against Mutations in the SCN Circadian Clock Network , 2007, Cell.

[69]  E. Campo,et al.  Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. , 2006, Endocrine-related cancer.

[70]  Masamitsu Iino,et al.  System-level identification of transcriptional circuits underlying mammalian circadian clocks , 2005, Nature Genetics.

[71]  T. Kubota,et al.  Anti‐tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation , 2004, Alimentary pharmacology & therapeutics.

[72]  Ook Joon Yoo,et al.  PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[73]  L. Fu,et al.  The circadian clock: pacemaker and tumour suppressor , 2003, Nature Reviews Cancer.

[74]  Takashi Sato,et al.  Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma , 2002, Cancer research.

[75]  J. Mariani,et al.  The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response. , 2001, EMBO reports.